Provident Trust Company’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-880,093
Closed -$69.1M 32
2017
Q1
$69.1M Sell
880,093
-5,017
-0.6% -$401K 3.47% 13
2016
Q4
$69.8M Sell
885,110
-12,221
-1% -$989K 3.66% 13
2016
Q3
$79.9M Buy
897,331
+38,287
+4% +$3.61M 4.48% 12
2016
Q2
$82.2M Sell
859,044
-712
-0.1% -$71K 4.53% 13
2016
Q1
$89.2M Buy
859,756
+3,067
+0.4% +$298K 4.79% 13
2015
Q4
$83.8M Buy
856,689
+16,920
+2% +$1.66M 4.43% 13
2015
Q3
$81M Buy
839,769
+1,699
+0.2% +$179K 4.56% 12
2015
Q2
$87.9M Buy
+838,070
New +$85.6M 4.95% 13

Other funds holding CVS

Provident Trust Company's CVS Position: Q2 2017 in Review

Provident Trust Company sold out of CVS Health (CVS) in Q2 2017, closing a stake of 880,093 shares — an estimated $69.1M sold.

Provident Trust Company first reported a position in CVS in Q2 2015 and held it in 8 quarters. The position peaked at $89.2M in Q1 2016. 1,552 funds tracked by Wall St. Rank hold CVS as of Q2 2017.

  • Provident Trust Company reported no remaining CVS Health position as of Q2 2017 after selling out during the quarter.
  • Provident Trust Company sold 880,093 CVS Health shares in Q2 2017, an estimated $69.1M.
  • Provident Trust Company first reported a position in CVS Health in Q2 2015 and held it in 8 quarters.
  • Provident Trust Company's CVS Health position peaked at $89.2M in Q1 2016.
  • 1,552 funds tracked by Wall St. Rank held CVS Health as of Q2 2017.

Based on Provident Trust Company's 13F filing for Q2 2017, filed 7 Aug 2017.